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Focal Eosinophilic Necrosis 
of the Liver in Patients with Underlying
Gastric or Colorectal Cancer: 
CT Differentiation from Metastasis
Objective: To determine the helical CT findings which help differentiate
between focal eosinophilic necrosis (FEN) of the liver and metastasis in patients
with underlying gastric or colorectal cancer.
Materials and Methods: In 21 patients with underlying gastric and colorectal
cancer examined during a recent 18-month period, the presence of FEN (n=90)
was proven at CT. The diagnosis was verified by biopsy in eight patients and by
the transient nature of the findings related to peripheral eosinophilia (>10%) in the
remainder. For comparison, 20 consecutive patients with pathologically proven
hepatic metastasis from gastric or colorectal cancer (n=158) were selected.
Single-phase helical CT images (7-mm collimation, pitch 1:1) were independently
analyzed in a random order by two blinded readers. The parameters evaluated
included the margin (depicted border, fuzzy), shape (spherical, non-spherical),
attenuation (subtle hypoattenuation, hypoattenuation), and the presence or
absence of rim enhancement.
Results: FEN far more frequently showed a fuzzy margin (81%, 84%), subtle
hypoattenuation (89%, 91%), and a non-spherical shape (84% for both readers)
than metastasis, for which the respective findings were 6%, 22%; 20%, 39%; and
15%, 23%. Rim enhancement was seldom found in FEN (0%, 2%), but was rec-
ognized by both readers in 40% of metastases. For all parameters, the results
were statistically significant (p < .01), and showed that both readers correctly dif-
ferentiated FEN from metastasis in 78% of the patients (32/41). Interobserver
agreement was, in addition, excellent ( = 0.66).
Conclusion: When focal hepatic lesions with a fuzzy margin, non-spherical
shape and subtle hypoattenuation without rim enhancement are found, the possi-
bility of FEN should be considered even in patients with underlying gastrointestinal
malignancy.
ocal eosinophilic necrosis (FEN) of the liver is one of various focal hepatic
lesions caused by eosinophil-related tissue damage (1). Since eosinophilia
can occur in a variety of pathologic conditions such as allergic reactions,
parasitic infestations, connective tissue disorders and neoplastic diseases, FEN compris-
es a number of heterogeneous eosinophilia-related conditions. Although the entity has
not been clearly defined and the mechanisms are not fully understood, FEN has re-
cently received much attention. It is mentioned in imaging studies far more frequently
than in the past, and is consequently often confused with other focal hepatic lesions.
FEN is particularly problematic when found in patients with underlying malignancy.
At preoperative CT it is apt to be misinterpreted as metastasis, especially when first
appearing during follow-up, and in such patients, correct interpretation of radiologic
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Findications that FEN may exist is critical to proper manage-
ment. Ultrasound (US) can be used to confirm the presence
of cysts (2, 3), but not of FEN, and for this reason, a way of
characterizing the latter on the basis of CT findings is need-
ed. Hence, we performed a comparative study to deter-
mine the helical CT features which help distinguish FEN
from metastasis in patients with underlying gastric and col-
orectal cancer.
MATERIALS AND METHODS
Patients selection
Using the radiologic information system, we searched
our departmental medical records dated November 1998
to April 2000 for patients whose final diagnosis was gastric
or colorectal cancer and who had also undergone contrast-
enhanced abdominal and pelvic CT using the protocol em-
ployed for the liver. We identified 21 consecutive patients
[M : F=15 : 6; age, 31 72 (mean, 54) years] with underly-
ing gastric or colorectal cancer in whom the presence of
FEN (n=90) was also proven, and these formed the study
population. In eight patients, the diagnosis of FEN (1) was
verified by percutaneous or intraoperative biopsy, and in
the remainder by consistent clinical findings of associated
peripheral eosinophilia (> 10%) followed by its sponta-
neous disappearance at CT after the peripheral blood
eosinophil count normalized. To avoid the possibility of
coincidental metastasis and eosinophilia, patients who un-
derwent chemotherapy during the follow-up period were
excluded. The peripheral eosinophil count was normal in
two of eight patients with pathologically proven FEN,
ranging from 0.4 to 21.7% (mean, 13.2%). Eighty-two
FENs in 18 patients were detected at initial preoperative
CT and the remaining eight, in three patients, were new
and detected during the follow-up period.
For the purpose of comparison, and using records cover-
ing the same period, 20 consecutive patients with patho-
logically proven hepatic metastasis (n=158) from gastric
(n=101) or colorectal cancer (n=57) were also selected.
CT Technique
In all cases, CT examinations were performed with a he-
lical CT scanner (HiSpeed Advantage; General Electric
Medical Systems, Milwaukee, Wis., U.S.A.) after the intra-
venous administration of 120 mL of nonionic contrast ma-
terial (Ultravist 300; Schering AG, Berlin, Germany) at a
rate of 2.5 mL/sec and with an injection delay of 70 sec-
onds. For patients with gastric cancer, helical mode scans
were obtained from the level of the hepatic dome to that
of the renal hilum, with patients in the prone position, and
with 7-mm collimation, a pitch of 1, and 7-mm reconstruc-
tion interval. These patients drank 500 800 mL of water
50 60 minutes before scanning and an additional 500 mL
just before scanning. Those with colorectal cancer under-
went scanning of the upper abdomen from the level of the
hepatic dome to the inferior tip of the liver, using the same
helical mode used for gastric cancer patients, and in the
supine position. For scanning of the rest of the abdomen
and pelvis, the clustered data acquisition mode (5-mm col-
limation and 5-mm interval) was used. Patients drank
600 900 mL of 2.5 % diluted sodium amidotrizoate and
meglumine amidotrizoate mixture (Gastrografin, Schering,
Germany) 50 60 minutes before CT scanning, and water
was administered rectally.
Image Analysis
Two experienced abdominal radiologists with no knowl-
edge of the final diagnoses independently analyzed single-
phase helical CT images of both FEN and metastasis in a
random order. The parameters evaluated included the
margin, attenuation, shape, and the presence or absence of
rim enhancement. The window settings of all CT images
were fixed at a width of 250 and a level of 30. The margin
was categorized as ‘depicted border’ or ‘fuzzy’, depending
on whether or not a complete margin could be drawn.
Attenuation was classified as either ‘subtle hypoattenua-
tion’ (discernibly lower than that of hepatic parenchyma)
or ‘hypoattenuation’ (higher than that of bile in the gall-
bladder and lower than ‘subtle hypoattenuation’), and
shape as either spherical or non-spherical. The presence or
absence of a rim enhancement pattern (hypoattenuation at
the center surrounded circumferentially by a less hypoat-
tenuating border) was determined. For statistical analysis
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Fig. 1. Focal eosinophilic necrosis of the liver in a 51-year-old
man with gastric cancer and peripheral eosinophilia (11.7%).
Contrast-enhanced CT scan obtained during the portal venous
phase shows that in both hepatic lobes, several non-spherical le-
sions (arrows) with a fuzzy margin are present, and there is sub-
tle hypoattenuation without rim enhancement.of each parameter, the chi-square test or Fisher’s exact test
was used, and degree of interobserver agreement was ex-
pressed by means of a kappa statistic; as suggested by
Landis and Koch (4), a  value greater than 0.60 indicated
excellent agreement, between 0.40 and 0.60 was good,
and less than 0.40 was poor.
RESULTS
The results of image analysis are summarized in Table 1.
FEN (Fig. 1) far more frequently showed a fuzzy margin
(81%, 84%), subtle hypoattenuation (89%, 91%), and
non-spherical shape (85%, 84%) than metastasis, for
which the corresponding figures were 6%, 22%; 20%,
39%; and 15%, 23%. Rim enhancement was seldom
found in FEN (0%, 2%), whereas it was recognized by
both readers in 40% of cases involving metastasis. For all
four parameters, these results were statistically significant
(p < .01), and there was also excellent interobserver agree-
ment ( > 0.60). Both readers correctly differentiated FEN
from metastasis in 78% of patients (32/41).
DISCUSSION
Although ‘focal eosinophilic necrosis’ is a descriptive
term based on pathologic features and has not yet  been
clearly defined, its imaging findings have lately attracted
considerable attention because in daily practice the condi-
tion often gives rise to diagnostic dilemmas. Most radiolog-
ic reports, however, have focused on hypereosinophilic
syndrome (5 9), a clinically distinct entity from FEN af-
fecting patients with mild eosinophilia (1) such as those de-
scribed in this study. As FEN is in most cases detected inci-
dentally and usually manifests at CT as multiple hypoat-
tenuating lesions, differentiation from metastasis has been
a problem, particularly in patients with underlying extra-
hepatic malignancies.
At multiphasic helical CT, FEN is generally most conspic-
uous during the portal venous phase (Fig. 2) but is often
not visualized during the hepatic arterial or equilibrium
Jang et al.
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Fig. 2. Contrast-enhanced helical CT scan of focal eosinophilic
necrosis of the liver in a 49-year-old man with colon cancer and pe-
ripheral eosinophilia (13.1%). 
A. Hepatic arterial-phase image depicts a minimally conspicuous
but very suspicious lesion (arrow) in the right hepatic lobe. 
B. Portal venous-phase image reveals greater lesion conspicuity
(straight arrow) than is apparent in A. Also visible are two additional
lesions (curved arrows). 
C. Image obtained after a three-minute delay depicts no recogniz-
able lesions.phase (1, 5), and this may be why it was seldom an issue in
the era of conventional CT. Owing to the optimal hepatic
parenchymal enhancement achieved by helical CT (10),
the incidence of FEN at imaging studies appears to be in-
creasing, giving rise to a clinical problem. Since single, por-
tal phase CT is generally performed for routine work-up
for metastasis or follow-up, characterization of FEN and its
differentiation from metastasis on the basis of single-phase
CT findings is needed.
Our results showed that FENs were far more likely to
have a fuzzy margin, and be non-spherical in shape and
subtly hypoattenuating. In addition, it is noteworthy that
rim enhancement was seen almost exclusively in metastasis
and seldom - in up to only 2% of cases - in FEN. Because
its incidence in cases involving metastasis is low (40%),
and it may thus not be a good indicator of this, rim en-
hancement could be a helpful feature in discriminating
metastasis from FEN. Metastatic nodules tend to outgrow
their blood supply, producing central necrosis and umbili-
cation (11), and these features could be represented as tar-
get or rim enhancement. On the other hand, FEN is usually
unaccompanied by a peripheral collection of histiocytes or
fibroblasts, as seen in granulomas or abscesses, that could
produce peripheral enhancement. In pathologic terms, FEN
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Table 2. Suggested Algorithmic Approach for Focal Eosinophilic Necrosis of the Liver in Patients with Gastric or Colorectal
Cancer
Incidental lesion at initial CT New lesion at follow-up CT
Findings Typical Equivocal Typical  Equivocal
Eosinophilia   +     +             + or  +
Diagnose as Biopsy Biospy
FEN, with          
follow-up CT      If not feasible
Do not assume as metastasis;
Short-term follow-up CT required
Fig. 3. Metastases from rectal cancer first evident at follow-up CT
performed seven months after surgery in a 62-year-old man.
Contrast-enhanced helical CT scan obtained during the portal ve-
nous phase shows small hypoattenuating lesions (arrows) with
an obvious rim- or target-like enhancement pattern.
Table 1. Analysis of Helical CT Images of Focal Eosinophilic Liver Necrosis and Metastasis of the Liver in 41 Patients with
Gastric or Colorectal Cancer
Parameter Category
FEN (n=90) Metastasis (n=158)
Reader 1 Reader 2 Reader 1 Reader 2
Margin Fuzzy 73 (81) 76 (84) 009 (6)00 35 (22)
Depicted border 14 (16) 17 (19) 123 (78) 149 (94)
Attenuation Subtle hypoattenuation 80 (89) 82 (91) 032 (20) 062 (39)
Hypoattenuation 8 (9) 10 (11) 096 (61) 126 (80)
Shape Non-spherical 76 (84) 76 (84) 024 (15) 036 (23)
Spherical 14 (16) 14 (16) 122 (77) 134 (85)
Rim enhancement Present 0 (0) 02 (2)00 63 (40) 063 (40)
Note. FEN = focal eosinophilic necrosis, Figures in parentheses are percentages., Statistical analysis showed p < .01 and  > 0.60 for all four
parameters.Jang et al.
244 Korean J Radiol 3(4), December 2002
is basically a focal area of heptaocellular necrosis caused
by severe eosinophilic infiltration of the perivascular space
(1), and this may explain the frequently-noted irregular
shape and fuzzy margins.
Among the 90 FENs in our study, 82 lesions were detect-
ed at initial preoperative CT and the remaining eight were
new, and detected during the follow-up period. Where
small indeterminate hepatic lesions occur, an absence of
change compared with prior imaging findings is generally
recognized as characteristic of benignancy (12); converse-
ly, new focal hepatic lesions found during follow-up in on-
cologic patients have usually been considered metastatic
(Fig. 3). Radiologists are thus perplexed to find that in such
patients, a new hepatic nodule could be due to a benign
transient condition such as FEN, and familiarity with the
CT findings of FEN and radiologic suggestion of the disease
may play a pivotal role in its proper management.
In our experience, FEN seems to almost always be ac-
companied by peripheral eosinophilia. However, the pe-
ripheral eosinophil count was normal in two of our eight
patients with pathologically-proven FEN, and it may thus
be assumed that among indeterminate lesions classified as
‘non-FEN’ due to a lack of peripheral eosinophilia, FEN
may be actually present. Even in oncologic patients with-
out eosinophilia, when indeterminate hepatic lesions show
CT findings consistent with FEN, biopsy should be per-
formed before deciding that they are metastatic (Table 2).
Malignancies such as lymphoma, leukemia and carcino-
ma are often reported to be associated with eosinophilia;
hence, eosinophil-related hepatic damage, such as the FEN
described in our study, may arise. One report noted the oc-
currence of this phenomenon in lymphoma cases involving
the tumor-associated eosinophilotactic factor, which is
identical to the eosinophil-chemotactic factor of anaphy-
laxis (13). In our experience, FEN not infrequently occurs
in patients with gastrointestinal malignancies, and might al-
so be due to factors derived from the tumors themselves;
because FEN could, therefore, indicate the presence of tu-
mor foci at other sites, care must be exercised when FENs
are observed during follow-up.
Our study suffers certain limitations. First, not all FENs
were pathologically proven. Partly because familiarity with
the CT findings of FEN has reduced the need for further in-
vasive study, and partly because FEN is not clearly visible
at US, biopsy was not always performed. Although we
confirmed the benign nature of the lesions by observing
their complete resolution at follow-up CT and by excluding
patients who underwent chemotherapy during the follow-
up period, we still cannot be absolutely certain that no oth-
er transient benign conditions existed. Second, our study
included only patients with gastric or colorectal cancers,
and whether these results can be generally applied to pa-
tients with various types of malignancy is thus open to de-
bate.
In summary, when focal hepatic lesions have a fuzzy
margin, are non-spherical in shape, and show homoge-
neous subtle hypoattenuation without rim enhancement,
the possibility of FEN should be considered even in pa-
tients with underlying gastrointestinal malignancy.
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